Immune to Cancer: The CRI Blog
-
ASCO18 Update: Vaccines, CAR T Cells, and OX40 Checkpoint Therapy
The first day of ASCO18 highlighted diverse immunotherapies, including vaccines, CAR T cells, and novel checkpoint drugs
-
30 Days of CRI Impact
Throughout Cancer Immunotherapy Month in June we’ll be highlighting the 30 most important CRI-funded breakthroughs.
-
ASCO18: Delivering Discoveries – Expanding the Reach of Precision Medicine
The world’s largest clinical cancer conference returns to Chicago June 1-5
-
Creating for the Cure: An Epic Podcast Fundraising Event
This year’s Livestream for the Cure podcast event lasted 30 hours and raised over $5,000 for cancer research,…
-
Jenny’s Immunotherapy Story
Lymphoma There’s life during cancer, too. Especially when I was doing immunotherapy. Jenny’s Story Jenny was still… -
Jami’s Immunotherapy Story
Lymphoma | Diagnosed 1994 In my history of cancer treatments, I’ve had to be really persistent to stay… -
Andy P’s Immunotherapy Story
Prostate Cancer | Diagnosed 2014 Immunotherapy is a new and lasting treatment for cancer. Andy’s Story Faced with… -
Going “Through the Kitchen” to Cure Cancer
Cancer Research Institute held its annual Through the Kitchen benefit party yesterday evening and raised $1.4 million to…
-
Second CAR T Cell Immunotherapy Approved for Patients with Lymphoma
A second CAR T cell immunotherapy targeting the CD19 receptor was approved by the FDA for patients…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.